IQVIA HOLDINGS INC (QTS.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:QTS - US46266C1053 - Common Stock
198.45 EUR
+2.35 (+1.2%)
We assign a fundamental rating of 4 out of 10 to QTS. QTS was compared to 19 industry peers in the Life Sciences Tools & Services industry. QTS has an excellent profitability rating, but there are concerns on its financial health. QTS has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
QTS had positive earnings in the past year.
In the past year QTS had a positive cash flow from operations.
Each year in the past 5 years QTS has been profitable.
QTS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
QTS's Return On Assets of 4.47% is fine compared to the rest of the industry. QTS outperforms 68.42% of its industry peers.
QTS has a Return On Equity of 20.83%. This is amongst the best in the industry. QTS outperforms 94.74% of its industry peers.
QTS's Return On Invested Capital of 9.77% is fine compared to the rest of the industry. QTS outperforms 73.68% of its industry peers.
QTS had an Average Return On Invested Capital over the past 3 years of 8.99%. This is in line with the industry average of 7.47%.
The last Return On Invested Capital (9.77%) for QTS is above the 3 year average (8.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.47% | ||
| ROE | 20.83% | ||
| ROIC | 9.77% |
ROA(3y)4.83%
ROA(5y)3.91%
ROE(3y)21.26%
ROE(5y)16.88%
ROIC(3y)8.99%
ROIC(5y)7.35%
1.3 Margins
The Profit Margin of QTS (8.07%) is comparable to the rest of the industry.
QTS's Profit Margin has improved in the last couple of years.
QTS has a Operating Margin of 14.20%. This is comparable to the rest of the industry: QTS outperforms 42.11% of its industry peers.
QTS's Operating Margin has improved in the last couple of years.
QTS has a Gross Margin of 33.78%. This is comparable to the rest of the industry: QTS outperforms 42.11% of its industry peers.
In the last couple of years the Gross Margin of QTS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.2% | ||
| PM (TTM) | 8.07% | ||
| GM | 33.78% |
OM growth 3Y13.09%
OM growth 5Y13.9%
PM growth 3Y8.58%
PM growth 5Y38.92%
GM growth 3Y1.42%
GM growth 5Y0.42%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so QTS is still creating some value.
QTS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, QTS has less shares outstanding
QTS has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.08 indicates that QTS is not a great score, but indicates only limited risk for bankruptcy at the moment.
QTS has a worse Altman-Z score (2.08) than 63.16% of its industry peers.
QTS has a debt to FCF ratio of 6.76. This is a slightly negative value and a sign of low solvency as QTS would need 6.76 years to pay back of all of its debts.
QTS has a Debt to FCF ratio of 6.76. This is comparable to the rest of the industry: QTS outperforms 52.63% of its industry peers.
A Debt/Equity ratio of 2.08 is on the high side and indicates that QTS has dependencies on debt financing.
QTS has a worse Debt to Equity ratio (2.08) than 89.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.08 | ||
| Debt/FCF | 6.76 | ||
| Altman-Z | 2.08 |
ROIC/WACC1
WACC9.74%
2.3 Liquidity
A Current Ratio of 0.70 indicates that QTS may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.70, QTS is doing worse than 89.47% of the companies in the same industry.
QTS has a Quick Ratio of 0.70. This is a bad value and indicates that QTS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of QTS (0.70) is worse than 63.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
QTS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.09%.
The Earnings Per Share has been growing by 11.72% on average over the past years. This is quite good.
QTS shows a small growth in Revenue. In the last year, the Revenue has grown by 3.85%.
The Revenue has been growing slightly by 6.80% on average over the past years.
EPS 1Y (TTM)7.09%
EPS 3Y7.25%
EPS 5Y11.72%
EPS Q2Q%5.63%
Revenue 1Y (TTM)3.85%
Revenue growth 3Y3.55%
Revenue growth 5Y6.8%
Sales Q2Q%5.24%
3.2 Future
Based on estimates for the next years, QTS will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.39% on average per year.
The Revenue is expected to grow by 5.88% on average over the next years.
EPS Next Y7.83%
EPS Next 2Y8.21%
EPS Next 3Y9.12%
EPS Next 5Y10.39%
Revenue Next Year5.27%
Revenue Next 2Y5.28%
Revenue Next 3Y5.47%
Revenue Next 5Y5.88%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.77 indicates a rather expensive valuation of QTS.
Based on the Price/Earnings ratio, QTS is valued a bit cheaper than 73.68% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.15, QTS is valued a bit cheaper.
QTS is valuated rather expensively with a Price/Forward Earnings ratio of 17.63.
73.68% of the companies in the same industry are more expensive than QTS, based on the Price/Forward Earnings ratio.
QTS is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.12, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.77 | ||
| Fwd PE | 17.63 |
4.2 Price Multiples
QTS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. QTS is cheaper than 63.16% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, QTS is valued cheaper than 84.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.68 | ||
| EV/EBITDA | 15.32 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
QTS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.53
PEG (5Y)1.69
EPS Next 2Y8.21%
EPS Next 3Y9.12%
5. Dividend
5.1 Amount
No dividends for QTS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:QTS (11/26/2025, 7:00:00 PM)
198.45
+2.35 (+1.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.98%
Inst Owner ChangeN/A
Ins Owners0.86%
Ins Owner ChangeN/A
Market Cap33.74B
Revenue(TTM)15.90B
Net Income(TTM)1.28B
Analysts83.45
Price Target196.08 (-1.19%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.2%
Min EPS beat(2)-0.04%
Max EPS beat(2)0.45%
EPS beat(4)2
Avg EPS beat(4)0.34%
Min EPS beat(4)-0.62%
Max EPS beat(4)1.56%
EPS beat(8)5
Avg EPS beat(8)0.55%
EPS beat(12)8
Avg EPS beat(12)0.59%
EPS beat(16)12
Avg EPS beat(16)1.02%
Revenue beat(2)1
Avg Revenue beat(2)-0.01%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)0.4%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-0.41%
Max Revenue beat(4)0.5%
Revenue beat(8)3
Avg Revenue beat(8)0.07%
Revenue beat(12)4
Avg Revenue beat(12)-0.19%
Revenue beat(16)6
Avg Revenue beat(16)-0.16%
PT rev (1m)4.39%
PT rev (3m)N/A
EPS NQ rev (1m)0.01%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.23%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.77 | ||
| Fwd PE | 17.63 | ||
| P/S | 2.46 | ||
| P/FCF | 17.68 | ||
| P/OCF | 13.94 | ||
| P/B | 6.35 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.32 |
EPS(TTM)10.04
EY5.06%
EPS(NY)11.26
Fwd EY5.67%
FCF(TTM)11.23
FCFY5.66%
OCF(TTM)14.24
OCFY7.17%
SpS80.75
BVpS31.28
TBVpS-73.59
PEG (NY)2.53
PEG (5Y)1.69
Graham Number84.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.47% | ||
| ROE | 20.83% | ||
| ROCE | 11.17% | ||
| ROIC | 9.77% | ||
| ROICexc | 10.83% | ||
| ROICexgc | N/A | ||
| OM | 14.2% | ||
| PM (TTM) | 8.07% | ||
| GM | 33.78% | ||
| FCFM | 13.9% |
ROA(3y)4.83%
ROA(5y)3.91%
ROE(3y)21.26%
ROE(5y)16.88%
ROIC(3y)8.99%
ROIC(5y)7.35%
ROICexc(3y)9.76%
ROICexc(5y)7.99%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.28%
ROCE(5y)8.4%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y16.83%
ROICexc growth 5Y22.05%
OM growth 3Y13.09%
OM growth 5Y13.9%
PM growth 3Y8.58%
PM growth 5Y38.92%
GM growth 3Y1.42%
GM growth 5Y0.42%
F-Score5
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.08 | ||
| Debt/FCF | 6.76 | ||
| Debt/EBITDA | 3.78 | ||
| Cap/Depr | 52.48% | ||
| Cap/Sales | 3.73% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 82.76% | ||
| Profit Quality | 172.33% | ||
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 2.08 |
F-Score5
WACC9.74%
ROIC/WACC1
Cap/Depr(3y)57.12%
Cap/Depr(5y)53.97%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.59%
Profit Quality(3y)136.6%
Profit Quality(5y)225.89%
High Growth Momentum
Growth
EPS 1Y (TTM)7.09%
EPS 3Y7.25%
EPS 5Y11.72%
EPS Q2Q%5.63%
EPS Next Y7.83%
EPS Next 2Y8.21%
EPS Next 3Y9.12%
EPS Next 5Y10.39%
Revenue 1Y (TTM)3.85%
Revenue growth 3Y3.55%
Revenue growth 5Y6.8%
Sales Q2Q%5.24%
Revenue Next Year5.27%
Revenue Next 2Y5.28%
Revenue Next 3Y5.47%
Revenue Next 5Y5.88%
EBIT growth 1Y4.3%
EBIT growth 3Y17.1%
EBIT growth 5Y21.64%
EBIT Next Year21.15%
EBIT Next 3Y11.05%
EBIT Next 5Y9.71%
FCF growth 1Y67.37%
FCF growth 3Y-2.8%
FCF growth 5Y20.42%
OCF growth 1Y42.92%
OCF growth 3Y-2.63%
OCF growth 5Y13.9%
IQVIA HOLDINGS INC / QTS.DE FAQ
What is the ChartMill fundamental rating of IQVIA HOLDINGS INC (QTS.DE) stock?
ChartMill assigns a fundamental rating of 4 / 10 to QTS.DE.
Can you provide the valuation status for IQVIA HOLDINGS INC?
ChartMill assigns a valuation rating of 5 / 10 to IQVIA HOLDINGS INC (QTS.DE). This can be considered as Fairly Valued.
What is the profitability of QTS stock?
IQVIA HOLDINGS INC (QTS.DE) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for QTS stock?
The Price/Earnings (PE) ratio for IQVIA HOLDINGS INC (QTS.DE) is 19.77 and the Price/Book (PB) ratio is 6.35.
What is the expected EPS growth for IQVIA HOLDINGS INC (QTS.DE) stock?
The Earnings per Share (EPS) of IQVIA HOLDINGS INC (QTS.DE) is expected to grow by 7.83% in the next year.